All In Biotech

Drug Trial Radar · NCT02216227

Checklist to Prevent MRSA Surgical Site Infections

Last checked: Nov 19, 2026Latest source record: Mar 31, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

23,005

Actual

Start

Apr 1, 2014

Primary completion

Feb 28, 2021

Study completion Feb 28, 2021

Sponsor

Lead sponsor
VA Office of Research and DevelopmentFederal agency
Sponsor type
Federal agency
First posted
Aug 13, 2014

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Prevention
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goals of this project are 1) to assess the effectiveness and cost-effectiveness of the checklist to prevent MRSA SSIs among Veterans undergoing TJA or cardiac surgery, and 2) to assess barriers and facilitators to checklist implementation. Hypotheses: 1. The SSI checklist will be effective at reducing MRSA SSIs among total joint arthroplasty and cardiac surgery patients. 2. Implementation of the checklist will be associated with an overall reduction in SSIs caused by all pathogens. 3. The SSI Checklist will be cost-saving since it will prevent many expensive SSIs. 4. Preoperative MRSA testing will be a modifiable barrier to implementing the SSI checklist.

Conditions

  • Surgical Site Infection

Interventions

  • MupirocinDrug

    Patients with known positive MRSA or MSSA and patients who have unknown status will decolonize BID x 5 days

  • Chlorhexidine gluconateDrug

    Patients that are MRSA or MSSA positive or have unknown status will bathe in CHG daily x 5 days. Patients that are MRSA or MSSA negative will bathe with CHG the night before and morning of surgery.

  • CefazolinDrug

    All patients will receive Cefazolin during surgery

  • VancomycinDrug

    Patients who are positive for MRSA, or have unknown MRSA status, will receive vancomycin along with cefazolin during surgery.

  • Nasal Povidone IodineDrug

    The purpose of this research is to evaluate a SSI checklist. This checklist includes decolonizing a patient's nose and skin and optimizing antibiotics prior to surgery. At the time that we wrote it, the predominate product to decolonize patient's noses was mupirocin. However, in 2017, an FDA final monograph stated that nasal povidone-iodine may be used for pre-surgical decolonization. Nasal povidone-iodine should be able to overcome barriers to checklist implementation that we identified in Aim 3. We now plan to replace the nasal agent mupirocin with the nasal agent povidone-iodine at 3 participating medical centers (Iowa City VA, Minneapolis VA and Portland VA) to assess whether this overcomes the barriers to our SSI checklist.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Participants With Superficial and Deep/Organ Space MRSA Infections Within 90 DaysTime frame: 90 days postoperatively

Locations

11 sites in 1 country. Site status is shown where the registry gives one.

  • Miami VA Healthcare System, Miami, FL

    Miami, Florida

  • Iowa City VA Health Care System, Iowa City, IA

    Iowa City, Iowa

  • Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD

    Baltimore, Maryland

  • VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA

    Boston, Massachusetts

  • VA Ann Arbor Healthcare System, Ann Arbor, MI

    Ann Arbor, Michigan

  • Minneapolis VA Health Care System, Minneapolis, MN

    Minneapolis, Minnesota

  • Omaha VA Nebraska-Western Iowa Health Care System, Omaha, NE

    Omaha, Nebraska

  • VA Portland Health Care System, Portland, OR

    Portland, Oregon

  • South Texas Health Care System, San Antonio, TX

    San Antonio, Texas

  • VA Salt Lake City Health Care System, Salt Lake City, UT

    Salt Lake City, Utah

  • William S. Middleton Memorial Veterans Hospital, Madison, WI

    Madison, Wisconsin

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.